Table 5 Adverse events
From: Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis
Adverse event | Number of patients (%) |
|---|---|
None | 8 (24) |
Pneumonia | 6 (18) |
Leukopenia | 5 (15) |
Infusion reaction | 4 (12) |
Minor infection* | 3 (9) |
Paraesthesias | 2 (6) |
Anaphylaxis | 4 (12) |
Flare of cutaneous disease | 1 (3) |
Chest pain | 1 (3) |
Headache | 1 (3) |
Asthma | 1 (3) |
Permanent discontinuation due to adverse event | 7 (21) |